PMGC Holdings Inc. (NASDAQ:ELAB) Sees Large Growth in Short Interest

PMGC Holdings Inc. (NASDAQ:ELAB) was the target of a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 129,521 shares, a growth of 322.1% from the January 29th total of 30,685 shares. Approximately 25.7% of the company’s shares are short sold. Based on an average daily trading volume, of 4,241,514 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 4,241,514 shares, the days-to-cover ratio is presently 0.0 days. Approximately 25.7% of the company’s shares are short sold.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

PMGC Stock Down 5.7%

NASDAQ ELAB opened at $1.16 on Thursday. The firm’s 50 day moving average is $3.84 and its 200-day moving average is $15.84. The company has a market capitalization of $580,000.00, a PE ratio of -0.02 and a beta of 0.70. PMGC has a 12-month low of $1.08 and a 12-month high of $130.34.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.